This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Importance of CD4+CD25+ly in UC1. Investigation of Difference Between Blood Concentration IL 17, IL 33, Regulatory T ly in Patients With UC and Control Group

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2008 by Clinical Hospital Center, Split.
Recruitment status was:  Recruiting
Information provided by:
Clinical Hospital Center, Split Identifier:
First received: December 8, 2008
Last updated: NA
Last verified: December 2008
History: No changes posted
Mucosal inflammation in patients with UC is the result of immunosuppression disturbance because decreasing number of regulatory T ly and activation IL 17

Ulcerative Colitis

Study Type: Observational
Study Design: Observational Model: Case Control

Resource links provided by NLM:

Further study details as provided by Clinical Hospital Center, Split:

Estimated Enrollment: 32
Study Start Date: September 2008
control group
patients with UC
patients with UC, without corticosteroid or immunosuppressive therapy


Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
patients with UC and control group

Inclusion Criteria:

  • endoscopic confirmed diagnosis

Exclusion Criteria:

  • corticosteroid or immunosuppressive therapy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00805428

Contact: Jasna Ajdukovic, MSc 0917983374

Klinički bolnički centar Split Recruiting
Split, Croatia
Contact: Jasna Ajdukovic, MSc    0917983374   
Sponsors and Collaborators
Clinical Hospital Center, Split
  More Information

Responsible Party: Jasna Ajdukovic, General practice Identifier: NCT00805428     History of Changes
Other Study ID Numbers: UC
Study First Received: December 8, 2008
Last Updated: December 8, 2008

Additional relevant MeSH terms:
Colitis, Ulcerative
Gastrointestinal Diseases
Digestive System Diseases
Inflammatory Bowel Diseases
Colonic Diseases
Intestinal Diseases processed this record on September 21, 2017